Related references
Note: Only part of the references are listed.CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer
Jihye Kim et al.
GYNECOLOGIC ONCOLOGY (2020)
Antitumor effects of a covalent cyclin-dependent kinase 7 inhibitor in colorectal cancer
Jian Wang et al.
ANTI-CANCER DRUGS (2019)
A Novel mTORC1/2 Inhibitor (MTI-31) Inhibits Tumor Growth, Epithelial-Mesenchymal Transition, Metastases, and Improves Antitumor Immunity in Preclinical Models of Lung Cancer
Qianwen Zhang et al.
CLINICAL CANCER RESEARCH (2019)
Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXRhighPD-L1low NSCLC to Anti-PD-1 Immunotherapy
Wenjie You et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity
Lifeng Li et al.
MOLECULAR CANCER (2019)
THZ1 suppresses human non-small-cell lung cancer cells in vitro through interference with cancer metabolism
Zhu-Jun Cheng et al.
ACTA PHARMACOLOGICA SINICA (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma
Lei Jiang et al.
PATHOLOGY (2019)
A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8(+) T cells
Ruihua Ma et al.
NATURE CELL BIOLOGY (2018)
Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells
Begona Canovas et al.
CANCER CELL (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis
Jian Wang et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
Ming Yi et al.
MOLECULAR CANCER (2018)
Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma
Demeng Chen et al.
BONE RESEARCH (2018)
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Matthew A. Coelho et al.
IMMUNITY (2017)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity
Chen Zhang et al.
MOLECULAR CANCER (2017)
Structures of transcription pre-initiation complex with TFIIH and Mediator
S. Schilbach et al.
NATURE (2017)
TFIIH generates a six-base-pair open complex during RNAP II transcription initiation and start-site scanning
Eric J. Tomko et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells
J. Feng et al.
ONCOGENE (2017)
BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer
J. Wang et al.
ONCOGENE (2017)
Metformin Attenuates Radiation-Induced Pulmonary Fibrosis in a Murine Model
Jian Wang et al.
RADIATION RESEARCH (2017)
TFIIH generates a six-base-pair open complex during RNAP II transcription initiation and start-site scanning
Eric J. Tomko et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Human TFIIH Kinase CDK7 Regulates Transcription-Associated Chromatin Modifications
Christopher C. Ebmeier et al.
CELL REPORTS (2017)
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
Michael J. Topper et al.
CELL (2017)
Checkpoint Blockade in Lung Cancer and Mesothelioma
Lysanne A. Lievense et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
Bo Li et al.
CANCER RESEARCH (2017)
The BET bromodomain inhibitor JQ1 radiosensitizes non-small cell lung cancer cells by upregulating p21
Jian Wang et al.
CANCER LETTERS (2017)
Transcriptional Addiction in Cancer
James E. Bradner et al.
CELL (2017)
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer
Hetal Patel et al.
CLINICAL CANCER RESEARCH (2016)
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey et al.
SCIENCE (2016)
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
Yubao Wang et al.
CELL (2015)
Objective Measurement and Clinical Significance of TILs in Non-Small Cell Lung Cancer
Kurt A. Schalper et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing
Kyle A. Nilson et al.
MOLECULAR CELL (2015)
REGγ is critical for skin carcinogenesis by modulating the Wnt/β-catenin pathway
Lei Li et al.
NATURE COMMUNICATIONS (2015)
Objective Measurement and Clinical Significance of TILs in Non-Small Cell Lung Cancer
Kurt A. Schalper et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT
D-W Wu et al.
ONCOGENE (2015)
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Camilla L. Christensen et al.
CANCER CELL (2014)
CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
Edmond Chipumuro et al.
CELL (2014)
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nicholas Kwiatkowski et al.
NATURE (2014)
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Meital Gabay et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Non-small-cell lung cancers: a heterogeneous set of diseases
Zhao Chen et al.
NATURE REVIEWS CANCER (2014)
Biomarker Discovery in Non-Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation
Johan Botling et al.
CLINICAL CANCER RESEARCH (2013)
RNA Polymerase II Elongation Control
Qiang Zhou et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
TFIIH: when transcription met DNA repair
Emmanuel Compe et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II
Stephane Larochelle et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
Hypoxia-inducible factor I and dysregulated c-myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
Jung-Whan Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Tristetraprolin regulates Cyclin D1 and c-myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling
M. Marderosian et al.
ONCOGENE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
